Myelination

Peripheral Neuropathy

Volumn 1, Issue , 2005, Pages 411-431

  Suter, Ueli ^a   Martini, Rudolf ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33745234330     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-9491-7.50022-3     Document Type: Chapter

References (210)

1. Abrams C.K., Oh S., Ri Y., Bargiello T.A. Mutations in connexin 32: the molecular and biophysical bases for the X-linked form of Charcot-Marie-Tooth disease. Brain Res. Rev. 2000, 32:203.
2. Adlkofer K., Martini R., Aguzzi A., et al. Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice. Nat. Genet. 1995, 11:274.
3. Altevogt B.M., Kleopa K.A., Postma F.R., et al. Connexin29 is uniquely distributed within myelinating glial cells of the central and peripheral nervous systems. J. Neurosci. 2002, 22:6458.
4. Anzini P., Neuberg D.H.H., Schachner M., et al. Structural abnormalities and deficient maintenance of peripheral nerve myelin in mice lacking the gap junction protein connexin 32. J. Neurosci. 1997, 17:4545.
5. Arroyo E.J., Scherer S.S. On the molecular architecture of myelinated fibers. Histochem. Cell Biol. 2000, 113:1.
6. Arroyo E.J., Xu Y.-T., Zhou L., et al. Myelinating Schwann cells determine the internodal localization of Kv1. 1, Kv1.2, Kvβ2, and Caspr. J. Neurocytol. 1999, 28:333.
7. Baechner D., Liehr T., Hameister H., et al. Widespread expression of the peripheral myelin protein-22 gene (pmp22) in neural and non-neural tissues during murine development. J. Neurosci. Res. 1995, 42:733.
8. Balice-Gordon R.J., Bone L.J., Scherer S.S. Functional gap junctions in the Schwann cell myelin sheath. J. Cell Biol. 1998, 142:1095.
9. Baxter R.V., Ben Othmane K., Rochelle J.M., et al. Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21. Nat. Genet. 2002, 30:21.
10. Bejaoui K., Wu C., Scheffler M.D., et al. SPTLC1 is mutated in hereditary sensory neuropathy, type 1. Nat. Genet. 2001, 27:261.
11. Bennett V., Lambert S., Davis J.Q., Zhang X. Molecular architecture of the specialized axonal membrane at the node of Ranvier. Soc. Gen. Physiol. Ser. 1997, 52:107.
12. Bentley C.A., Lee K.F. p75 is important for axon growth and Schwann cell migration during development. J. Neurosci. 2000, 20:7706.
13. Berger P., Young P., Suter U. Molecular cell biology of Charcot-Marie-Tooth disease. Neurogenetics 2002, 4:1.
14. Berthold C.H. Development of nodes of Ranvier in feline nerves: an ultrastructural presentation. Microsc. Res. Tech. 1996, 34:399.
15. Bhattacharyya A., Frank E., Ratner N., Brackenbury R. P0 is an early marker of the Schwann cell lineage in chickens. Neuron 1991, 7:831.
16. Billings-Gagliardi S. Mode of locomotion of Schwann cells migrating in vivo. Am. J. Anat. 1977, 150:73.
17. Billings-Gagliardi S., Webster H.d., O'Connel M.F. In vivo and electron microscopic observations on Schwann cells in developing tadpole nerve fibers. Am. J. Anat. 1974, 141:375.
18. Boerkoel C., Takashima H., Stankiewicz P., et al. Periaxin mutations cause recessive Dejerine-Sottas neuropathy. Am. J. Hum. Genet. 2001, 68:325.
19. Bondurand N., Girard M., Pingualt V., et al. Human connexin 32, a gap junction protein altered in Charcot-MarieTooth disease, is directly regulated by the transcription factor SOX10. Hum. Mol. Genet. 2001, 10:2783.
20. Borycki A.G., Emerson C.P. Muscle determination: another key player in myogenesis? Curr. Biol. 1997, 7:R620.
21. Boyle M.E., Berglund E.O., Murai K.K., et al. Contactin orchestrates assembly of the septate-like junctions at the paranode in myelinated peripheral nerve. Neuron 2001, 30:385.
22. Brancolini C., Edomi P., Marzinotto S., Schneider C. Exposure at the cell surface is required for gas3/PMP22 to regulate both cell death and cell spreading: implication for the Charcot-Marie-Tooth type 1A and Dejerine-Sottas diseases. Mol. Biol. Cell 2000, 11:2901.
23. Britsch S., Goerich D.E., Riethmacher D., et al. The transcription factor Sox10 is a key regulator of peripheral glial development. Genes Dev. 2001, 15:66.
24. Brown A.M., Lemke G. Multiple regulatory elements control transcription of the peripheral myelin protein zero gene. J. Biol. Chem. 1997, 272:28939.
25. Bunge R.P., Bunge M.B., Bates M. Movements of the Schwann cell nucleus implicate progression of the inner (axon-related) Schwann cell process during myelination. J. Cell Biol. 1989, 109:273.
26. Caduff J., Sansano S., Bonnet A., et al. Characterization of GFP-MAL expression and incorporation in rafts. Microsc. Res. Tech. 2001, 52:645.
27. Campagnoni A.T., Skoff R.P. The pathobiology of myelin mutants reveal novel biological functions of the MBP and PLP genes. Brain Pathol. 2001, 11:74.
28. Carenini S., Montag D., Cremer H., et al. Absence of myelin-associated glycoprotein (MAG) and the neural cell adhesion molecule (N-CAM) interferes with the maintenance, but not with the formation of peripheral myelin. Cell Tissue Res. 1997, 287:3.
29. Carenini S., Montag D., Schachner M., Martini R. MAG-deficient Schwann cells myelinate dorsal root ganglion cells in culture. Glia 1998, 22:213.
30. Chandross K.J., Cohen R.I., Paras P., et al. Identification and characterization of early glial progenitors using a transgenic selection strategy. J. Neurosci. 1999, 19:759.
31. Chen L.M., Bailey D., Fernandez-Valle C. Association of beta 1 integrin with focal adhesion kinase and paxillin in differentiating Schwann cells. J. Neurosci. 2000, 20:3776.
32. Cheng L., Mudge A.W. Cultured Schwann cells constitutively express the myelin protein P0. Neuron 1996, 16:309.
33. Chernousov M.A., Carey D.J. Schwann cell extracellular matrix molecules and their receptors. Histol. Histopathol. 2000, 15:593.
34. Ciutat D., Caldero J., Oppenheim R.W., Esquerda J.E. Schwann cell apoptosis during normal development and after axonal degeneration induced by neurotoxins in the chick embryo. J. Neurosci. 1996, 16:3979.
35. Cravioto H. The role of Schwann cells in the development of human peripheral nerves: an electron microscopic study. J. Ultrastruct. Res. 1965, 12:634.
36. Cuesta A., Pedrola L., Sevilla T., et al. The gene encoding ganglioside-induced differentiation-associated protein 1 is mutated in axonal Charcot-Marie-Tooth type 4A disease. Nat. Genet. 2002, 30:22.
37. Dawkins J.L., Hulme D.J., Brahmbhatt S.B., et al. Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I. Nat. Genet. 2001, 27:309.
38. De Bellard M.E., Filbin M.T. Myelin-associated glycoprotein, MAG, selectively binds several neuronal proteins. J. Neurosci. Res. 1999, 56:213.
39. de Waegh S.M., Lee V.M.Y., Brady S.T. Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells. Cell 1992, 68:451.
40. Dickson K.M., Bergeron J.J., Shames I., et al. Association of calnexin with mutant peripheral myelin protein-22 ex vivo: a basis for "gain-of-function" ER diseases. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:9852.
41. Ding Y., Brunden K.R. The cytoplasmic domain of myelin glycoprotein P0 interacts with negatively charged phospholipid bilayers. J. Biol. Chem. 1994, 269:10764.
42. Domeniconi M., Cao Z., Spencer T., et al. Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth. Neuron 2002, 35:283.
43. Dong Z., Sinanan A., Parkinson D., et al. Schwann cell development in embryonic mouse nerves. J. Neurosci. Res. 1999, 56:334.
44. Dupree J.L., Popko B. Genetic dissection of myelin galactolipid function. J. Neurocytol. 1999, 28:271.
45. D'Urso D., Brophy P.J., Staugaitis S.M., et al. Protein zero of peripheral nerve myelin: biosynthesis, membrane insertion, and evidence for homotypic interaction. Neuron 1990, 2:449.
46. D'Urso D., Ehrhardt P., Mμller H.W. Peripheral myelin protein 22 and protein zero: a novel association in peripheral nervous system myelin. J. Neurosci. 1999, 19:3396.
47. Dytrych L., Sherman D.L., Gillespie C.S., Brophy P.J. Two PDZ domain proteins encoded by the murine periaxin gene are the result of alternative intron retention and are differentially targeted in Schwann cells. J. Biol. Chem. 1998, 273:5794.
48. Einheber S., Zanazzi G., Ching W., et al. The axonal membrane protein Caspr, a homologue of neurexin IV, is a component of the septate-like paranodal junctions that assemble during myelination. J. Cell Biol. 1997, 139:1495.
49. Erne B., Sansano S., Frank M., Schaeren-Wiemers N. Rafts in adult peripheral nerve myelin contain major structural myelin proteins and myelin and lymphocyte protein (MAL) and CD59 as specific markers. J. Neurochem. 2002, 82:550.
50. Fannon A.M., Sherman D.L., Ilynia G., et al. Novel E-Cadherin-mediated adhesion in peripheral nerve: Schwann cell architecture is stabilized by autotypic adherens junctions. J. Cell Biol. 1995, 129:189.
51. Feltri L., Scherer S.S., Nemni R., et al. beta;4 integrin expression in myelinating Schwann cells is polarized, developmentally regulated and axonally dependent. Development 1994, 120:1287.
52. Feltri M.L., D'Antonio M., Quattrini A., et al. A novel P0 glycoprotein transgene activates expression of lacZ in myelin-forming Schwann cells. Eur. J. Neurol. 1999, 11:1577.
53. Feltri M.L., Graus Porta D., Previtali S.C., et al. Conditional disruption of beta 1 integrin in Schwann cells impedes interactions with axons. J. Cell Biol. 2002, 156:199.
54. Fernandez-Valle C., Fregien N., Wood P.M., Bunge M.B. Expression of the protein zero myelin gene in axonrelated Schwann cells is linked to basal lamina formation. Development 1993, 119:867.
55. Fernandez-Valle C., Gorman D., Gomez A.M., Bunge M.B. Actin plays a role in both changes in cell shape and gene expression associated with Schwann cell myelination. J. Neurosci. 1997, 17:241.
56. Fernandez-Valle C., Gwynn L., Wood P.W., et al. Anti-β1 integrin antibody inhibits Schwann cell myelination. J. Neurobiol. 1994, 25:1207.
57. Fernandez-Valle C., Tang Y., Ricard J., et al. Paxillin binds schwannomin and regulates its density-dependent localization and effect on cell morphology. Nat. Genet. 2002, 31:354.
58. Filbin M.T, Walsh F.S., Trapp B.D., et al. Role of myelin P0 protein as a homophilic adhesion molecule. Nature 1990, 344:871.
59. Forghani R., Garofalo L., Foran D.R., et al. A distal upstream enhancer from the myelin basic protein gene regulates expression in myelin-forming Schwann cells. J. Neurosci. 2001, 21:3780.
60. Fraher J.P., O'Leary D., Moran M.A., et al. Relative growth and maturation of axon size and myelin thickness in the tibial nerve of the rat. 1. Normal animals. Acta Neuropathol. 1990, 79:364.
61. Frank M. MAL, a proteolipid in glycosphingolipid enriched domains: functional implications in myelin and beyond. Prog. Neurobiol. 2000, 60:531.
62. Frank M., Atanasoski S., Sancho S., et al. Progressive segregation of unmyelinated axons in peripheral nerves, myelin alterations in the CNS, and cyst formation in the kidneys of myelin and lymphocyte protein-overexpressing mice. J. Neurochem. 2000, 75:1927.
63. Frei R., Dowling J., Carenini S., et al. Myelin formation by Schwann cells in the absence of β4 integrin. Glia 1999, 27:269.
64. Friede R.L., Beuche W. A new approach toward analyzing peripheral nerve fiber populations. I. Variance in sheath thickness corresponds to different geometric proportions of the internodes. J. Neuropathol. Exp. Neurol. 1985, 44:60.
65. Fruttiger M., Montag D., Schachner M., Martini R. Crucial role for the myelin-associated glycoprotein in the maintenance of axon-myelin integrity. Eur. J. Neurosci. 1995, 7:511.
66. Gao Y., Li W., Filbin M.T. Acylation of myelin P0 protein is required for adhesion. J. Neurosci. Res. 2000, 60:704.
67. Garbay B., Heape A.M., Sargueil F, Cassagne C. Myelin synthesis in the peripheral nervous system. Prog. Neurobiol. 2000, 61:267.
68. Gatzinsky K.P. Node-paranode regions as local degradative centres in alpha-motor axons. Microsc. Res. Tech. 1996, 34:492.
69. Ghislain J., Desmarquet-Trin-Dinh C., Jaegle M., et al. Characterisation of cis-acting sequences reveals a biphasic, axon-dependent regulation of Krox20 during Schwann cell development. Development 2002, 129:155.
70. Gillespie C.S., Sherman D.L., Blair G.E., Brophy P.J. Periaxin, a novel protein of myelinating Schwann cells with a possible role in axon ensheathment. Neuron 1994, 12:497.
71. Gillespie C.S., Sherman D.L., Fleetwood-Walker S.M., et al. Peripheral demyelination and neuropathic pain behavior in periaxin-deficient mice. Neuron 2000, 26:523.
72. Gould R.M., Byrd A.L., Barbarese E. The number of Schmidt-Lanterman incisures is more than doubled in shiverer PNS myelin sheaths. J. Neurocytol. 1995, 24:85.
73. Gravel M., Di Polo A., Valera P.B., Braun P.E. Four-kilobase sequence of the mouse CNP gene directs spatial and temporal expression of lacZ in transgenic mice. J. Neurosci. Res. 1998, 53:393.
74. Guilbot A., Williams A., Ravise N., et al. A mutation in periaxin is responsible for CMT4F, an autosomal recessive form of Charcot-Marie-Tooth disease. Hum. Mol. Genet. 2001, 10:415.
75. Hagedorn L., Suter U., Sommer L. P0 and PMP22 mark a multipotent neural crest-derived cell type that displays community effects in response to TGF-βfamily factors. Development 1999, 126:3781.
76. Hahn A.F., Whitaker J.N., Kachar B., Webster H.d. P2, P1, and P0 myelin protein expression in developing rat sixth nerve: a quantitative immunocytochemical study. J. Comp. Neurol. 1987, 260:501.
77. Hai M., Bidichandani S.I., Hogan M.E., Patel P.I. Competitive binding of triplex-forming oligonucleotides in the two alternate promoters of the PMP22 gene. Antisense Nucleic Acid Drug Dev. 2001, 11:233.
78. Hamacher M., Pippirs U., Köhler A., et al. Plasmolipin: genomic structure, chromosomal localization, protein expression pattern, and putative association with Bardet-Biedl syndrome. Mamm. Genome 2001, 12:933.
79. Hasse B., Bosse F., Muller H.W. Proteins of peripheral myelin are associated with glycosphingolipid/cholesterol-enriched membranes. J. Neurosci. Res. 2002, 69:227.
80. Inoue K., Tanabe Y., Lupski J.R. Myelin deficiencies in both the central and the peripheral nervous systems associated with a SOX10 mutation. Ann. Neurol. 1999, 46:313.
81. Jaegle M., Meijer D. Role of Oct-6 in Schwann cell differentiation. Microsc. Res. Tech. 1998, 41:372.
82. Jones K.J., Morgan G., Johnston H., et al. The expanding phenotype of laminin alpha2 chain (merosin) abnormalities: case series and review. J. Med. Genet. 2001, 38:649.
83. Kelm S., Schauer R., Crocker P.R. The siaload-hesins-a family of sialic acid-dependent cellular recognition molecules within the immunoglobulin superfamily. Glycoconj. J. 1996, 13:913.
84. Kimura M., Sato M., AkatsGBRa A., et al. Overexpression of a minor component of myelin basic protein isoform (17.2 kDa) can restore myelinogenesis in transgenic shiverer mice. Brain Res. 1998, 785:245.
85. Kirschner D.A., Ganser A.L. Compact myelin exists in the absence of basic protein in the shiverer mutant mouse. Nature 1980, 283:207.
86. Koenig H.L., Schumacher M., Ferzaz B., et al. Progesterone synthesis and myelin formation by Schwann cells. Science 1995, 268:1500.
87. Kuhlbrodt K., Herbarth B., Sock E., et al. Sox10, a novel transcriptional modulator in glial cells. J. Neurosci. 1998, 18:237.
88. Lai C., Brow M.A., Nave K.A., et al. Two forms of 1B236/myelin-associated glycoprotein, a cell adhesion molecule for postnatal neural development, are produced by alternative splicing. Proc. Natl. Acad. Sci. U. S. A. 1987, 84:4337.
89. Landry C.F., Ellison J.P., Skinner E., Campagnoni A.T. Golli-MBP proteins mark the earliest stages of fiber extension and terminal arboration in the mouse peripheral nervous system. J. Neurosci. Res. 1997, 50:265.
90. Le Douarin N., Dulac C., Dupin E., Cameron-Curry P. Glia cell lineages in the neural crest. Glia 1991, 4:175.
91. Lee A.G. Myelin: delivery by raft. Curr. Biol. 2001, 11:R60.
92. Lee M.J., Brennan A., Blanchard A., et al. P0 is constitutively expressed in the rat neural crest and embryonic nerves and is negatively and positively regulated by axons to generate non-myelin forming and myelin forming Schwann cells, respectively. Mol. Cell. Neurosci. 1997, 8:336.
93. Lemke G. Unwrapping the genes of myelin. Neuron 1988, 1:535.
94. Lemke G. The molecular genetics of myelination: an update. Glia 1993, 7:263.
95. Lemke G., Lamar E., Patterson J. Isolation and analysis of the gene encoding peripheral myelin protein zero. Neuron 1988, 1:73.
96. Li C., Tropak M.B., Gerial R., et al. Myelination in the absence of myelin-associated glycoprotein. Nature 1994, 369:747.
97. Li X., Lynn B.D., Olson C., et al. Connexin29 expression, immunocytochemistry and freeze-fracture replica immunogold labelling (FRIL) in sciatic nerve. Eur. J. Neurosci. 2002, 16:795.
98. Linn S.C., Kim H.S., Keane E.M., et al. Regulation of de novo sphingolipid biosynthesis and the toxic consequences of its disruption. Biochem. Soc. Trans. 2001, 29:831.
99. Lobsiger C.S., Schweitzer B., Taylor V., Suter U. Platelet-derived growth factor-BB supports the survival of cultured rat Schwann cell precursors in synergy with neurotrophin-3. Glia 2000, 30:290.
100. Lobsiger C.S., Taylor V., Suter U. The early life of a Schwann cell. Biol. Chem. 2002, 383:245.
101. Magnaghi V., Cavarretta I., Galbiati M., et al. Neuroactive steroids and peripheral myelin proteins. Brain Res. Brain Res. Rev. 2001, 37:360.
102. Magyar J., Ebensperger C., Schaeren-Wiemers N., Suter U. Myelin and lymphocyte protein (MAL/MVP17/VIP17) and plasmolipin are members of an extended gene family. Gene 1997, 189:269.
103. Maier M., Berger P., Nave K.A., Suter U. Identification of the regulatory region of the peripheral myelin protein 22 (PMP22) gene that directs temporal and spatial expression in development and regeneration of peripheral nerves. Mol. Cell. Neurosci. 2002, 20:93.
104. Maier M., Berger P., Suter U. Understanding Schwann cell-neurone interactions: the key to Charcot-Marie-Tooth disease?. J. Anat. 2002, 200:357.
105. Mallon B.S., Shick H.E., Kidd G.J., Macklin W.B. Proteolipid promoter activity distinguishes two populations of NG2-positive cells throughout neonatal cortical development. J. Neurosci. 2002, 22:876.
106. Mandemakers W., Zwart R., Jaegle M., et al. A distal Schwann cell-specific enhancer mediates axonal regulation of the Oct-6 transcription factor during peripheral nerve development and regeneration. EMBO J. 2000, 19:2992.
107. Martin S., Levine A.K., Chen Z.J., et al. Deposition of the NG2 proteoglycan at nodes of Ranvier in the peripheral nervous system. J. Neurosci. 2001, 21:8119.
108. Martini R. Expression and functional roles of neural cell surface molecules and extracellular matrix components during development and regeneration of peripheral nerves. J. Neurocytol. 1994, 23:1.
109. Martini R. The effect of myelinating Schwann cells on axons. Muscle Nerve 2001, 24:456.
110. Martini R., Bollensen E., Schachner M. Immunocytological localization of the major peripheral nervous system glycoprotein P0 and the L2/HNK-1 and L3 carbohydrate structures in developing and adult mouse sciatic nerve. Dev. Biol. 1988, 129:330.
111. Martini R., Mohajeri M.H., Kasper S., et al. Mice doubly deficient in the genes for P0 and myelin basic protein show that both proteins contribute to the formation of the major dense line in peripheral nerve myelin. J. Neurosci. 1995, 15:4488.
112. Martini R., Schachner M. Immunoelectron microscopic localization of neural cell adhesion molecules (L1, N-CAM, and MAG) and their shared carbohydrate epitope and myelin basic protein in developing sciatic nerve. J. Cell Biol. 1986, 103:2439.
113. Maurel P., Salzer J.L. Axonal regulation of Schwann cell proliferation and survival and the initial events of myelination requires PI 3-kinase activity. J. Neurosci. 2000, 20:4635.
114. Melendez-Vasquez C.V., Rios J.C., Zanazzi G., et al. Nodes of Ranvier form in association with ezrin-radixin-moesin (ERM)-positive Schwann cell processes. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:1235.
115. Menegoz M., Gaspar P., Le Bert M., et al. Paranodin, a glycoprotein of neuronal paranodal membranes. Neuron 1997, 19:319.
116. Menichella D.M., Arroyo E.J., Awatramani R., et al. Protein zero is necessary for E-cadherin-mediated adherens junction formation in Schwann cells. Mol. Cell. Neurosci. 2001, 18:606.
117. Mirsky R., Jessen K.R., Brennan A., et al. Schwann cells as regulators of nerve development. J. Physiol. Paris 2002, 96:17.
118. Montag D., Giese K.P., Bartsch U., et al. Mice deficient for the myelin-associated glycoprotein show subtle abnormalities in myelin. Neuron 1994, 13:229.
119. Nagarajan R., Svaren J., Le N., et al. EGR2 mutations in inherited neuropathies dominant-negatively inhibit myelin gene expression. Neuron 2001, 30:355.
120. Noakes P.G., Bennett M.R. Growth of axons into developing muscles of the chick forelimb is preceded by cells that stain with Schwann cell antibodies. J. Comp. Neurol. 1987, 259:330.
121. Notterpek L., Roux K.J., Amici S.A., et al. Peripheral myelin protein 22 is a constituent of intercellular junctions in epithelia. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:14404.
122. Notterpek L., Ryan M.C., Tobler A.R., Shooter E.M. PMP22 accumulation in aggresomes: implications for CMT1A pathology. Neurobiol. Dis. 1999, 6:450.
123. Owens G.C., Boyd C.J. Expression antisense P0 RNA in Schwann cells perturbs myelination. Development 1991, 112:639.
124. Owens G.C., Bunge R.P. Schwann cells infected with a recombinant retrovirus expressing myelin-associated glycoprotein antisense RNA do not form myelin. Neuron 1991, 7:565.
125. Paratore C., Eichenberger C., Suter U., Sommer L. Sox10 haploinsufficiency affects maintenance of progenitor cells in a mouse model of Hirschsprung disease. Hum. Mol. Genet. 2002, 11:3075.
126. Paratore C., Goerich D.E., Suter U., et al. Survival and glial fate acquisition of neural crest cells are regulated by an interplay between the transcription factor Sox10 and extrinsic combinatorial signaling. Development 2001, 128:3949.
127. Paratore C., Hagedorn L., Floris J., et al. Cell-intrinsic and cell-extrinsic cues regulating lineage decisions in multipotent neural crest-derived progenitor cells. Int. J. Dev. Biol. 2002, 46:193.
128. Pareek S., Notterpek L., Snipes G.J., et al. Neurons promote translocation of peripheral myelin protein 22 into myelin. J. Neurosci. 1997, 17:7754.
129. Pareek S., Suter U., Snipes G.J., et al. Detection and processing of peripheral myelin protein PMP22 in cultured Schwann cells. J. Biol. Chem. 1993, 268:10372.
130. Parmantier E., Cabon F., Braun C., et al. Peripheral myelin protein-22 is expressed in rat and mouse brain and spinal cord motoneurons. Eur. J. Neurosci. 1995, 7:1080.
131. Pedraza L., Colman D.R. Fluorescent myelin proteins provide new tools to study the myelination process. J. Neurosci. Res. 2000, 60:697.
132. Peirano R.I., Goerich D.E., Riethmacher D., Wegner M. Protein zero gene expression is regulated by the glial transcription factor Sox10. Mol. Cell. Biol. 2000, 20:3198.
133. Peles E., Nativ M., Lustig M., et al. Identification of a novel contactin-associated transmembrane receptor with multiple domains implicated in protein-protein interactions. EMBO J. 1997, 16:978.
134. Peles E., Salzer J.L. Molecular domains of myelinated axons. Curr. Opin. Neurobiol. 2000, 10:558.
135. Peters A., Muir A.R. The relationship between axons and Schwann cells during development of peripheral nerves in the rat. Q. J. Exp. Physiol. 1959, 44:117.
136. Peters A., Palay S.L., Webster H.d. The Fine Structure of the Nervous System 1991, Oxford University Press, New York.
137. Phillips D.D., Hibbs R.G., Ellison J.P., Shapiro H. An electron microscopic study of central and peripheral nodes of Ranvier. J. Anat. 1972, 111:229.
138. Pingault V., Guiochon-Mantel A., Bondurand N., et al. Peripheral neuropathy with hypomyelination, chronic intestinal pseudo-obstruction and deafness: a developmental "neural crest syndrome" related to a SOX10 mutation. Ann. Neurol. 2000, 48:671.
139. Poliak S., Gollan L., Salomon D., et al. Localization of Caspr2 in myelinated nerves depends on axon-glia interactions and the generation of barriers along the axon. J. Neurosci. 2001, 21:7568.
140. Poltorak M., Sadoul R., Keilhauer G., et al. Myelinassociated glycoprotein, a member of the L2/HNK-1 family of neural cell adhesion molecules, is involved in neuronoligodendrocyte and oligodendrocyte-oligodendrocyte interaction. J. Cell Biol. 1987, 105:1893.
141. Popko B. Myelin galactolipids: mediators of axon-glial interactions?. Glia 2000, 29:149.
142. Previtali S.C., Feltri M.L., Archelos J.J., et al. Role of integrins in the peripheral nervous system. Prog. Neurobiol. 2001, 64:35.
143. Previtali S.C., Quattrini A., Fasolini M., et al. Epitope-tagged P(0) glycoprotein causes Charcot-Marie-Tooth-like neuropathy in transgenic mice. J. Cell Biol. 2000, 151:1035.
144. Privat A., Jacque C., Bourre J.M., et al. Absence of the major dense line in the myelin of the mutant mouse "shiverer." Neurosci. Lett. 1979, 12:107.
145. RambGBRkana A., Zanazzi G., Tapinos N., Salzer J.L. Contact-dependent demyelination by Mycobacterium leprae in the absence of immune cells. Science 2002, 296:927.
146. Readhead C., Popko B., Takahashi N., et al. Expression of a myelin basic protein gene in transgenic shiverer mice: correction of the dysmyelinating phenotype. Cell 1987, 48:703.
147. Ressot C., Bruzzone R. Connexin channels in Schwann cells and the development of the X-linked form of Charcot-Marie-Tooth disease. Brain Res. Rev. 2000, 32:192.
148. Riethmacher D., Sonnenberg-Rietmacher E., Brinkmann V., et al. Severe neuropathies in mice with targeted mutations in the ErbB3 receptor. Nature 1997, 389:725.
149. Roach A., Boylan K., Horvath S., et al. Characterization of cloned cDNA representing rat myelin basic protein: absence of expression in brain of shiverer mutant mice. Cell 1983, 34:799.
150. Rosenbluth J. Central myelin in the mouse mutant shiverer. J. Comp. Neurol. 1980, 194:639.
151. Rosenbluth J. Peripheral myelin in the mouse mutant shiverer. J. Comp. Neurol. 1980, 193:729.
152. Ryan M.C., Shooter E.M., Notterpek L. Aggresome formation in neuropathy models based on peripheral myelin protein 22 mutations. Neurobiol. Dis. 2002, 10:109.
153. Sancho S., Young P., Suter U. Regulation of Schwann cell proliferation and apoptosis in PMP22-deficient mice and mouse models of Charcot-Marie-Tooth disease type 1A. Brain 2001, 124:2177.
154. Sanes J.R., Lichtman J.W. Development of the vertebrate neuromuscular junction. Annu. Rev. Neurosci. 1999, 22:389.
155. Schachner M. Neural recognition molecules in disease and regeneration. Curr. Opin. Neurobiol. 1994, 4:726.
156. Schachner M., Martini R. Glycans and the modulation of neural recognition molecule function. Trends Neurosci. 1995, 18:183.
157. Scherer S.S. The biology and pathobiology of Schwann cells. Curr. Opin. Neurol. 1997, 10:386.
158. Scherer S.S. Myelination: some receptors required. J. Cell. Biol. 2002, 156:13.
159. Scherer S.S., Arroyo E.J. Recent progress on the molecular organization of myelinated axons. J. Peripher. Nerv. Syst. 2002, 7:1.
160. Scherer S.S., Deschênes S.M., Xu Y.T., et al. Connexin32 is a myelin-related protein in the PNS and CNS. J. Neurosci. 1995, 15:8281.
161. Scherer S.S., Xu T., Crino P., et al. Ezrin, radixin, and moesin are components of Schwann cell microvilli. J. Neurosci. Res. 2001, 65:150.
162. Scherer S.S., Xu Y.T., Bannerman P.G.C., et al. Periaxin expression in myelinating Schwann cells: modulation by axon-glial interactions and polarized localization during development. Development 1995, 121:4265.
163. Scherer S.S., Xu Y.-T., Nelles E., et al. Connexin32-null mice develop demyelinating peripheral neuropathy. Glia 1998, 24:8.
164. Schneider-Schaulies J., von Brunn A., Schachner M. Recombinant peripheral myelin protein P0 confers both adhesion and neurite outgrowth-promoting properties. J. Neurosci. Res. 1990, 27:286.
165. Schröder J.M., Bohl J., von Bardeleben U. Changes of the ratio between myelin thickness and axon diameter in human developing sural, femoral, ulnar, facial, and trochlear nerves. Acta Neuropathol. 1988, 76:471.
166. Schumacher M., Guennoun R., Mercier G., et al. Progesterone synthesis and myelin formation in peripheral nerves. Brain Res. Brain Res. Rev. 2001, 37:343.
167. Shapiro L., Doyle J.P., Hensley P., et al. Crystal structure of the extracellular domain from P0, the major structural protein of peripheral nerve myelin. Neuron 1996, 17:435.
168. Sherman D.L., Fabrizi C., Gillespie C.S., Brophy P.J. Specific disruption of a Schwann cell dystrophin-related protein complex in a demyelinating neuropathy. Neuron 2001, 30:677.
169. Shibata Y., Kumai M., Nishii K., Nakamura K. Diversity and molecular anatomy of gap junctions. Med. Electron Microsc. 2001, 34:153.
170. Simons K., Ikonen E. Functional rafts in cell membranes. Nature 1997, 387:569.
171. Smith-Slatas C., Barbarese E. Myelin basic protein gene dosage effects the PNS. Mol. Cell. Neurosci. 2000, 15:343.
172. Sohl G., Eiberger J., Jung Y.T., et al. The mouse gap junction gene connexin29 is highly expressed in sciatic nerve and regulated during brain development. Biol. Chem. 2001, 382:973.
173. Staugaitis S.M., Colman D.R., Pedraza L. Membrane adhesion and other functions for the myelin basic proteins. Bio Essays 1995, 18:13.
174. Stewart H.J. Expression of c-Jun, Jun B, Jun D and cAMP response element binding protein by Schwann cells and their precursors in vivo and in vitro. Eur. J. Neurosci. 1995, 7:1366.
175. Stoffel W., Bosio A. Myelin glycolipids and their functions. Curr. Opin. Neurobiol. 1997, 7:654.
176. Suter U., Snipes G.J. Biology and genetics of hereditary motor and sensory neuropathies. Annu. Rev. Neurosci. 1995, 18:45.
177. Suter U., Snipes G.J. Peripheral myelin protein 22: facts and hypotheses. J. Neurosci. Res. 1995, 40:145.
178. Suter U., Snipes G.J., Schoener-Scott R., et al. Regulation of tissue-specific expression of alternative peripheral myelin protein-22 (PMP22) gene transcripts by two promoters. J. Biol. Chem. 1994, 269:25795.
179. Tabernero A., Stewart H.J.S., Jessen K.R., Mirsky R. The neuron-glia signal beta neuregulin induces sustained CREB phosphorylation on Ser-133 in cultured rat Schwann cells. Mol. Cell. Neurosci. 1998, 10:309.
180. Tait S., Gunn-Moore F., Collinson J.M., et al. An oligodendrocyte adhesion molecule at the site of assembly of the paranodal axo-glial junction. J. Cell Biol. 2000, 150:657.
181. Takeichi M. The cadherins: cell-cell adhesion molecules controlling animal morphogenesis. Development 1988, 102:639.
182. Takeichi M. Cadherins: a molecular family important in selective cell-cell adhesion. Annu. Rev. Biochem. 1990, 59:237.
183. Taylor V., Zgraggen C., Naef R., Suter U. Membrane topology of peripheral myelin protein 22. J. Neurosci. Res. 2001, 62:15.
184. Tifft C.J., Proia R.L. Stemming the tide: glycosphingolipid synthesis inhibitors as therapy for storage diseases. Glycobiology 2000, 10:1249.
185. Toews A.D., Hostettler J., Barrett C., Morell P. Alterations in gene expression associated with primary demyelination and remyelination in the peripheral nervous system. Neurochem. Res. 1997, 22:1271.
186. Topilko P., Schneider-Maunoury S., Levi G., et al. Krox20 controls myelination in the peripheral nervous system. Nature 1994, 371:796.
187. Traka M., Dupree J.L., Popko B., Karagogeos D. The neuronal adhesion protein TAG-1 is expressed by Schwann cells and oligodendrocytes and is localized to the juxtaparanodal region of myelinated fibers. J. Neurosci. 2002, 22:3016.
188. Trapp B. Distribution of the myelin-associated glycoprotein and P0 protein during myelin compaction in quaking mouse peripheral nerve. J. Cell Biol. 1988, 107:675.
189. Trapp B.D., Andrews S.B., Wong A., et al. Co-localization of the myelin-associated glycoprotein and the microfilament components, F-actin and spectrin, in Schwann cells of myelinated nerve fibres. J. Neurocytol. 1989, 18:47.
190. Trapp B.D., O'Connell M.F., Andrews S.B. Ultrastructural immunolocalization of MAG and P0 proteins in cryosections of peripheral nerve. J. Cell Biol. 1986, 1035:228a.
191. Trapp B.D., Quarles R.H. Presence of the myelinassociated glycoprotein correlates with alterations in the periodicity of peripheral myelin. J. Cell Biol. 1982, 92:877.
192. Tropak M.B., Johnson P.W., Dunn R.J., Roder J.C. Differential splicing of MAG transcripts during CNS and PNS development. Brain Res. 1988, 464:143.
193. Vyas A.A., Schnaar R.L. Brain gangliosides: functional ligands for myelin stability and the control of nerve regeneration. Biochimie 2001, 83:677.
194. Warner L.E., Mancias P., Butler I.J., et al. Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies. Nat. Genet. 1998, 18:382.
195. Webster H.d. The geometry of peripheral myelin sheaths during their formation and growth in rat sciatic nerves. J. Cell Biol. 1971, 48:348.
196. Wegner M. Transcriptional control in myelinating glia: flavors and spices. Glia 2000, 31:1.
197. Wegner M. Transcriptional control in myelinating glia: the basic recipe. Glia 2000, 29:118.
198. Wong M.H., Filbin M.T. Dominant-negative effect on adhesion by myelin P0 protein truncated in its cytoplasmic domain. J. Cell Biol. 1996, 134:1531.
199. Wu R., Jurek M., Sundarababu S., Weinstein D.E. The POU gene Brn-5 is induced by neuregulin and is restricted to myelinating Schwann cells. Mol. Cell. Neurosci. 2001, 17:683.
200. Xu W., Shy M., Kamholz J., et al. Mutations in the cytoplasmic domain of P0 reveal a role for PKC-mediated phosphorylation in adhesion and myelination. J. Cell Biol. 2001, 155:439.
201. Yagi T., Takeichi M. Cadherin superfamily genes: functions, genomic
202. Yamashita T., Higuchi H., Tohyama M. The p75 receptor transduces the signal from myelin-associated glycoprotein to Rho. J. Cell Biol. 2002, 157:565.
203. Yang L.J.S., Zeller C.B., Shaper N.L., et al. Gangliosides are neural ligands for myelin-associated glycoprotein. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:814.
204. Yin X., Crawford T.O., Griffin J.W., et al. Myelinassociated glycoprotein is a myelin signal that modulates the caliber of myelinated axons. J. Neurosci. 1998, 18:1953.
205. Yin X., Kidd G.J., Wrabetz L., et al. Schwann cell myelination requires timely and precise targeting of P0 protein. J. Cell Biol. 2000, 148:1009.
206. Young P., Boussadia O., Berger P., et al. E-cadherin is required for the correct formation of autotypic adherens junctions of the outer mesaxon but not for the integrity of myelinated fibers of peripheral nerves. Mol. Cell. Neurosci. 2002, 21:341.
207. Young P., Suter U. Disease mechanisms and potential therapeutic strategies in Charcot-Marie-Tooth disease. Brain Res. Rev. 2001, 36:213.
208. Zanazzi G., Einheber S., Westreich R., et al. Glial growth factor/neuregulin inhibits Schwann cell myelination and induces demyelination. J. Cell Biol. 2001, 152:1289.
209. Ziskind-Conhaim L. Physiological and morphological changes in developing peripheral nerves of rat embryos. Dev. Brain Res. 1988, 42:15.
210. Zoidl G., Blass-Kampmann S., D'Urso D., et al. Retroviral-mediated gene transfer of the peripheral myelin protein PMP22 in Schwann cells: modulation of cell growth. EMBO J. 1995, 14:1122.